May 8 2008

Lobbyist groups are banging down the FDA's doors, asking the agency to yank the birth-control patch Ortho-Evra off pharmacists' shelves and insisting that it poses high risk of potentially-fatal blood clots and at much higher rates of instance than the drug companies are disclosing. The higher estrogen levels that